Source Naturals, MigraControl Petadolex Butterbur, 50mg, 60 softgels
UPC Code: 021078021049
Source Naturals MigraControl may ease tension and support vascular smooth muscle relaxation in the brain. This patented, standardized extract contains petasin and isopetasin, biologically active compounds which may have an affinity for cerebral blood vessels, and may support normal inflammation response by inhibiting leuketrine synthesis. MigraControl may be taken for other traditional uses.
Adults: 1 softgel three times daily with meals for four weeks. Thereafter, 1 softgel twice daily for four to six months. If necessary increase to 1 softgel three times daily. Adolescents: 10 to 17 years of age 1 softgel twice daily for four months. Children: 6 to 9 years of age 1 softgel daily. Not for use by children under the age of 6. You may begin the regimen anew as desired.
Petadolex Purple Butterbur Root Extract - (Petasites hybridus) standardized to 7.5 mg petasins - 50 mg
Other Ingredients: middle chain triglycerides, gelatin, glycerol, glucitol, purified water, and riboflavin.
About Source Naturals
Source Naturals was created in 1982 to support each individual's potential to enjoy optimal health. Source Naturals' comprehensive Bio-Aligned Formulas help bring the power of alignment to your body. When formulating, we evaluate the underlying causes of system imbalances, and then provide targeted nutrition to interdependent body systems. Our line of more than 600 products also includes well-researched, single entity nutrients in their highest quality and most bioavailable forms.
Do not use if pregnant or nursing. Keep out of reach of children. Please consult your health care provider if currently under care or treatment. Do not exceed recommended serving. See product packaging for additional safety information.
Individual results may vary. This product is not intended to diagnose, treat, cure or prevent any disease. The statements on this website and all affiliates have not been evaluated by the FDA. Advice on treatment or care of an individual patient should be obtained through consultation with a trained health care practitioner.